Vergoeding 2016-2020 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers

  • Raming voor de totale Zvw-populatie
  2016 2017 2018 2019 2020
J05AF01 Zidovudine (Retrovir ®) 46.755 43.575 32.785 19.823 13.410
J05AF02 Didanosine 72.288 38.300 648 . .
J05AF04 Stavudine 4.863 905 . . .
J05AF05 Lamivudine (Epivir ®) 723.910 592.810 529.170 424.540 297.600
J05AF06 Abacavir (Ziagen ®) 653.630 585.840 505.680 385.170 299.950
J05AF07 Tenofovirdisoproxil (Viread ®) 6.949.800 6.491.200 2.534.500 991.520 851.660
J05AF08 Adefovir (Hepsera ®) 431.190 377.140 340.800 245.680 187.960
J05AF09 Emtricitabine (Emtriva ®) 111.560 79.988 57.383 50.456 53.165
J05AF10 Entecavir (Baraclude ®) 7.099.800 7.478.300 3.425.200 1.483.900 1.614.400
J05AF11 Telbivudine (Sebivo ®) 21.624 22.045 24.060 19.588 1.860
J05AF13 Tenofoviralafenamide (Vemlidy ®) . 58.306 519.990 1.102.600 1.570.500
Totaal 16.115.420 15.768.409 7.970.216 4.723.277 4.890.505